Close Menu

Vela Diagnostics

The company also increased its number of authorized shares of common stock to 1.5 billion shares from 200 million shares. 

The approval from the firm's shareholders and board comes after Great Basin moved its stock to the Over-the-Counter market in October. 

The two-hour test requires about two minutes of hands-on time to detect multiple pathogens from stool samples. 

The firm was delisted from the Nasdaq during the third quarter, and reported a net loss of $29 million.

The company has received a number of warnings from the Nasdaq over the past year for its failure to meet the exchange's $35 million market value and $1 minimum bid price requirements.

The 1-for-80 split of the company's common stock, which will go into effect on Sept. 16, will reduce its outstanding shares to approximately 1 million.

The firm now has until Feb. 27, 2017 to achieve and maintain a $1 minimum list price on its shares for 10 consecutive days. 

Continued growth in its customer base and the adoption of the firm's Group B Strep assay drove the increase.

For the three months ended June 30, the Salt Lake City-based firm saw a 126 percent increase in US customers, from 115 to 260.

With the exception of $6 million available to the company immediately, the remainder will be distributed over 15 months beginning in February 2017.

Pages

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.